Campylobacter jejuni IgM Control Serum BC139M

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Campylobacter jejuni IgM Control Serum
Applications: ELISA
IgM control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC139M Categories: control serum, Virion/Serion kits Tags: Campylobacter jejuni, ELISA control serum, IgM

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Campylobacter jejuni reactive IgM
species reactivity	Campylobacter jejuni
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Campylobacter jejuni IgM Control Serum BC139M

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Campylobacter jejuni Antigen (BA139VS) Campylobacter jejuni IgA Control Serum (BC139A) Campylobacter jejuni IgG Control Serum (BC139G) Campylobacter jejuni IgM Control Serum (BC139M) Campylobacter jejuni IgA ELISA Kit (ESR139A) Campylobacter jejuni IgG ELISA Kit (ESR139G) Campylobacter jejuni IgM ELISA Kit (ESR139M)

target relevance

human antibody anti-Campylobacter jejuni

Campylobacter jejuni

Description
Bacterium that causes campylobacteriosis and bacterial gastroenteritis

Structure
Campylobacter jejuni is a Gram-negative, microaerophilic, curved or spiral-shaped bacterium belonging to the family Campylobacteraceae. The organism possesses one or more polar flagella that provide characteristic corkscrew-like motility, enabling movement through intestinal mucus and facilitating colonization of the gastrointestinal tract. C. jejuni is widely distributed among domestic and wild animals, particularly poultry, which serve as major reservoirs of human infection. The bacterium is one of the leading causes of bacterial gastroenteritis worldwide and is commonly transmitted through consumption of undercooked poultry, unpasteurized milk, contaminated water, or direct contact with infected animals. Campylobacter jejuni possesses numerous virulence factors that promote adherence, invasion, toxin production, and immune evasion, contributing to intestinal inflammation and disease.

Diagnosis
The diagnosis of Campylobacter jejuni infection is performed through microbiological, molecular, and antigen detection methods. Isolation of the organism from stool specimens using selective culture media under microaerophilic conditions remains a standard diagnostic approach. Polymerase chain reaction (PCR) assays provide rapid and highly sensitive detection of Campylobacter DNA and are increasingly included in multiplex gastrointestinal pathogen panels. Antigen detection assays may also be used in some clinical laboratories. Laboratory findings are often nonspecific but may include elevated inflammatory markers and fecal leukocytes. Accurate diagnosis is important because the clinical presentation can resemble infections caused by Salmonella, Shigella, pathogenic Escherichia coli, and other enteric pathogens.

Symptoms
Campylobacter jejuni infection typically develops following an incubation period of approximately two to five days after exposure. Clinical manifestations commonly include diarrhea, which may become bloody, abdominal cramping, fever, nausea, vomiting, headache, and malaise. The abdominal pain may be severe enough to mimic acute appendicitis. Most infections are self-limiting and resolve within several days to one week; however, severe disease may occur in young children, elderly individuals, and immunocompromised patients. Important post-infectious complications include reactive arthritis, irritable bowel syndrome, and Guillain-Barré syndrome, an autoimmune neurological disorder that can result in progressive muscle weakness and paralysis. In rare cases, bloodstream infection and other invasive complications may occur.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application of the Campylobacter jejuni IgM Control Serum BC139M?

The Campylobacter jejuni IgM Control Serum BC139M is designed for use as a control in ELISA assays, specifically for indirect and quantitative detection of Campylobacter jejuni reactive IgM antibodies.

How should the Campylobacter jejuni IgM Control Serum BC139M be stored to maintain its stability?

This control serum should be stored refrigerated at 2-8°C to preserve its stability and functionality for research use.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC139M protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Campylobacter jejuni IgM Control Serum BC139M

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Enterovirus IgM Control Serum BC133M

Campylobacter jejuni IgA Control Serum BC139A

Influenza B Virus IgM Control Serum BC1232M

Campylobacter jejuni IgG Control Serum BC139G

Helicobacter pylori IgM Control Serum BC118M

Brucella IgM Control Serum BC116M

Borrelia burgdorferi IgM Control Serum BC121M

Echovirus IgM Control Serum BC135M

Aspergillus fumigatus IgM Control Serum BC132M

Cytomegalovirus IgM Control Serum BC109M

Coxsackie IgM Virus Control Serum BC134M

Coxiella burnetii Phase 2 IgM Control Serum BC1312M

Chlamydia trachomatis IgM Control Serum BC1372M

Chlamydia pneumoniae IgM Control Serum BC1371M

Candida albicans IgM Control Serum BC117M